Answers are grounded in this paper and cite their sources.
Advanced glycation end products (AGEs) formed under hyperglycemic conditions contribute to diabetic complications and age-related disorders. This study investigated the protective effect of baicalein (BAC) against methylglyoxal (MGO)-induced glycation and structural alterations of human serum albumin (HSA). Glycation was induced by incubating HSA with MGO at 37°C for 7 days. The interaction between BAC and HSA was characterized using UV-visible and fluorescence spectroscopy, supported by thermodynamic and Förster Resonance Energy Transfer (FRET) analyses. Antiglycation activity was evaluated by measuring AGE formation and Thioflavin T (ThT) fluorescence. Cytoprotective effects were assessed in isolated human lymphocytes through DCFH-DA and MTT assays. Spectroscopic studies confirmed stable HSA-BAC complex formation, while thermodynamic analysis indicated a spontaneous interaction driven mainly by hydrogen bonding and van der Waals forces. BAC significantly reduced AGE formation and ThT fluorescence and improved cellular antioxidant status and viability. These findings highlight baicalein as a promising natural antiglycation agent against glycation-associated cellular damage.
No takes yet. Share an insight, caveat, or question.
Riaz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: